0 CHECKOUT

World In-vitro Fertilization (IVF) - Market Opportunities and Forecasts, 2014 - 2021

  • ID: 3338991
  • June 2015
  • Region: Global
  • 254 pages
  • Allied Analytics LLP
The Middle East Accounted for about 65% Revenue Share of the LAMEA IVF Market

FEATURED COMPANIES

  • Cadila Healthcare Ltd.
  • Clinica Anglo Americana
  • Clinique de la Muette
  • EMD Serono
  • Genea Biomedx
  • Klinikum Stuttgart
  • MORE

IVF procedures have emerged as a preferable choice for the fertility treatments in clinical industry. The market is poised to witness a remarkable growth, primarily due to the related technological advancements such as pre-implantation genetic diagnosis (PGD) and three-parent IVF procedures.

The global IVF market is expected to reach $11.3 billion by 2021, at a CAGR of 7.0% from 2015 to 2021. Reduction in conception rates mainly in women aged 40 years or above, delayed pregnancy in women suffering from gynecological conditions, changing lifestyle and fertility disorders are the major factors that drive the market growth. Other factors responsible for the market growth are favorable reimbursement scenario and the delayed parenthood opted by couples due to professional and financial constraints. On the other hand, ethical concerns in particular countries, high cost of the IVF procedures and low awareness, especially in under-developed economies such as Nigeria are likely to restrain the market growth.

The rising initiatives towards commercialization of cost-efficient treatments and emerging medical tourism, mainly in developing nations would offer lucrative growth opportunities READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cadila Healthcare Ltd.
  • Clinica Anglo Americana
  • Clinique de la Muette
  • EMD Serono
  • Genea Biomedx
  • Klinikum Stuttgart
  • MORE

Chapter: 1 INTRODUCTION
1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

Chapter: 3 GLOBAL IN VITRO FERTILIZATION (IVF) MARKET OVERVIEW
3.1 Market Definition and Scope
3.2 IVF pricing trends by country
3.3 IVF Cycles by Country
3.4 Global IVF Market by End Users
3.5 Market Dynamics
3.5.1 Drivers
3.5.1.1 Delayed pregnancies in women
3.5.1.2 Rise in global infertility rates
3.5.1.3 Emergence of new fertility tourism destinations
3.5.2 Restraints
3.5.2.1 Cost involved in the treatment
3.5.2.2 Low level of awareness in developing economies
3.5.2.3 Inadequate reimbursements policies for IVF treatments
3.5.2.4 Ethical Considerations
3.5.3 Opportunities
3.5.3.1 Market growth by relaxing the legal considerations
3.5.3.2 New technology development and treatment options
3.5.3.3 Three parent IVF
3.6 Key Findings

Chapter: 4 NORTH-AMERICA IVF MARKET
4.1 United States IVF Market, (revenue and Number of Cycles)
4.1.1 Number of IVF Cycles, 2014-2021
4.1.2 United States IVF Market, 2014-2021 ($Million)
4.1.3 Number of Infertility Clinics, 2014
4.2 United States IVF Market by End Users
4.2.1 Market Dynamics
4.2.1.1 Drivers
4.2.1.1.1 INCREASING POPULARITY OF IVF IN UNITED STATES
4.2.1.1.2 INCREASED RATE OF INFERTILITY AND PRACTICES OF EMBRYO BANKING CYCLES
4.2.1.2 Restraints
4.2.1.2.1 HIGH COST OF IVF IN UNITED SATES
4.2.1.2.2 BAN ON 3-PARENT IVF
4.2.1.2.3 SCATTERED REIMBURSEMENTS
4.2.2 Regulatory Issues, Legislations and Authorities
4.2.3 Insurance Reimbursement Scenario
4.2.4 Company Profile
4.2.4.1 Fertility and Gynecology Center Monterey Bay IVF
4.2.4.2 Conceptions Reproductive Associates
4.2.4.3 Servy Massey Fertility Institute
4.2.4.4 Sher Institute for Reproductive Medicine (SIRM)
4.2.4.5 Cardone Reproductive Medicine & Infertility
4.2.4.6 Fertility Center of San Antonio
4.2.4.7 Houston Fertility Center
4.2.4.8 New hope fertility center
4.2.4.9 Reproductive Medicine Associates Of New Jersey
4.3 Canada IVF Market (Revenue and Number of Cycles)
4.3.1 Number of IVF Cycles, 2014-2021
4.3.2 Canada IVF Market, 2014-2021 ($Million)
4.3.3 Number of infertility centres
4.4 Canada IVF Market by End users
4.4.1 Market Dynamics
4.4.1.1 Drivers
4.4.1.1.1 COMMERCIALIZATION OF IVF BOOSTER IN CANADA
4.4.1.2 Restraints
4.4.1.2.1 HIGH COST OF IVF IN CANADA
4.4.2 Regulatory Issues, Legislations and Authorities
4.4.3 Insurance Reimbursement Scenario
4.4.4 Company Profile
4.4.4.1 Toronto Centre for Advanced Reproductive Technology Ltd.
4.4.4.2 Fertility Treatment Center
4.4.4.3 Montreal Fertility Center
4.5 Mexico IVF Market (Revenue and Number of Cycles)
4.5.1 Number of IVF Cycles, 2014-2021
4.5.2 Mexico IVF Market, 2014-2021 ($Million)
4.5.3 Number of infertility centres
4.6 Mexico IVF Market by End Users
4.6.1 Market Dynamics
4.6.1.1 Drivers
4.6.1.1.1 FERTILITY TOURISM
4.6.1.1.2 COMPARATIVELY LOW COST OF IVF
4.6.1.2 Restraints
4.6.1.2.1 LANGUAGE BARRIERS
4.6.2 Regulatory Issues, Legislations and Authorities
4.6.3 Insurance Reimbursement Scenario
4.6.4 Company Profile
4.6.4.1 Liv Fertility Center In Puerto Vallarta
4.6.4.2 BFC Biofertility Center

Chapter: 5 EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)
5.1 Germany IVF Market (Revenue and Number of Cycles)
5.1.1 Number of IVF Cycles, 2014–2021
5.1.2 Germany IVF Market, 2014–2021 ($Million)
5.1.3 Number of infertility clinics
5.2 Germany IVF Market by End Users
5.2.1 Market Dynamics
5.2.1.1 Drivers
5.2.1.1.1 SUBSIDIZING IVF TREATMENTS
5.2.1.1.2 DELAYED MARRIAGES AND PARENTHOOD DECISIONS
5.2.1.2 Restraints
5.2.1.2.1 STRINGENT GOVERNMENT REGULATIONS
5.2.1.2.2 LACK OF AVAILABILITY IN TREATMENT CYCLES FOR IVF
5.2.2 Regulatory Issues, Legislations and Authorities
5.2.3 Insurance Reimbursement Scenario
5.2.4 Company Profile
5.2.4.1 Heidelberg University Hospital
5.2.4.2 Klinikum Stuttgart
5.2.4.3 DRK Kliniken Berlin
5.2.4.4 University Medical Center Freiburg
5.3 France IVF Market (Revenue and Number of Cycles)
5.3.1 Number of IVF Cycles, 2014–2021
5.3.2 France IVF Market, 2014–2021 ($Million)
5.3.3 Number of infertility centers
5.4 France IVF Market by End Users
5.4.1 Market Dynamics
5.4.1.1 Drivers
5.4.1.1.1 SAME GENDER ADOPTION OF IVF BABIES
5.4.1.1.2 LOWER RATES OF FERTILITY
5.4.1.2 Restraints
5.4.1.2.1 STRINGENT GOVERNMENT REGULATIONS
5.4.2 Regulatory Issues, Legislations and Authorities
5.4.3 Insurance Reimbursement Scenario
5.4.4 Company Profile
5.4.4.1 Clinique de la Muette
5.4.4.2 Hopital des metallurgists, hopital cochin
5.5 United Kingdom IVF Market (Revenue and Number of Cycles)
5.5.1 Number of IVF Cycles, 2014–2021
5.5.2 United Kingdom IVF Market, 2014–2021 ($Million)
5.5.3 Number of infertility centers
5.6 United Kingdom IVF Market by End Users
5.6.1 Market Dynamics
5.6.1.1 Drivers
5.6.1.1.1 COMMERCIALIZATION OF THREE-PARENT IVF PROCEDURES
5.6.1.1.2 SUPPORTIVE REGULATIONS
5.6.1.2 Restraints
5.6.1.2.1 ETHICAL CONSIDERATIONS
5.6.2 Regulatory Issues, Legislations and Authorities
5.6.3 Insurance Reimbursement Scenario
5.6.4 Company Profile
5.6.4.1 Lister Fertility Clinic
5.6.4.2 The Bridge Center
5.6.4.3 Chelsea and Westminster Hospital (Assisted Conception Unit)
5.7 Italy IVF Market (Revenue and Number of Cycles)
5.7.1 Number of IVF Cycles, 2014–2021
5.7.2 Italy IVF Market, 2014–2021 ($Million)
5.8 Italy IVF market by End users
5.8.1 Market Dynamics
5.8.1.1 Drivers
5.8.1.2 Restraints
5.8.1.2.1 BAN ON THE SURROGACY
5.8.2 Regulatory issues, legislations and authorities
5.8.3 Insurance Reimbursement Scenario
5.8.4 Company Profile
5.8.4.1 ARC-STER srl
5.8.4.2 RAPRUI
5.8.4.3 Centre for Reproductive Medicine-Napoli
5.9 Spain IVF Market (Revenue and Number of Cycles)
5.9.1 Number of IVF Cycles, 2014–2021
5.9.2 Spain IVF Market, 2014–2021 ($Million)
5.10 Spain IVF Market by End Users
5.10.1 Market Dynamics
5.10.1.1 Drivers
5.10.1.1.1 INCREASE IN THE NUMBER OF FOREIGN PATIENTS
5.10.1.2 Restraints
5.10.2 Regulatory Issues, Legislations and Authorities
5.10.3 Insurance Reimbursement Scenario
5.10.4 Company Profiles
5.10.4.1 IVF spain
5.10.4.2 Clínica EUGIN Barcelona
5.11 Denmark IVF Market (Revenue and Number Of Cycles)
5.11.1 Number of IVF Cycles, 2014–2021
5.11.2 Denmark IVF Market, 2014–2021 ($Million)
5.12 Denmark IVF Market by End Users
5.12.1 Market Dynamics
5.12.1.1 Drivers
5.12.1.1.1 INCREASE IN DISPOSABLE INCOME
5.12.1.1.2 ADVANCES IN IVF TECHNOLOGY
5.12.1.2 Restraints
5.12.1.2.1 INADEQUATE REIMBURSEMENT POLICIES
5.12.2 Regulatory Issues, Legislations and Authorities
5.12.3 Insurance Reimbursement Scenario
5.12.4 Company Profiles
5.12.4.1 Copenhagen Fertility Center
5.12.4.2 Storkklinik v/Nina Stork
5.12.4.3 Vitanova
5.12.4.4 trianglen fertility clinic
5.12.4.5 Nordica - Denmark, Copenhagen
5.13 Russia IVF Market (Revenue annd Number of Cycles)
5.13.1 Number of IVF Cycles, 2014–2021
5.13.2 Russia IVF Market, 2014–2021 ($Million)
5.14 Russia IVF Market by End Users
5.14.1 Market Dynamics
5.14.1.1 Drivers
5.14.1.1.1 RISING POPULARITY OF FERTILITY TOURISM
5.14.1.2 Restraints
5.14.1.2.1 INADEQUATE REIMBURSEMENT POLICIES
5.14.2 Regulatory Issues, Legislations and Authorities
5.14.3 Insurance Reimbursement Scenario
5.14.4 Company Profiles
5.14.4.1 ava-peter clinic
5.14.4.2 md medical group
5.14.4.3 ivf russia (The International Centre of the Reproductive Medicines)
5.15 Other Europe IVF Market (Revenue and Number of Cycles)
5.15.1 Number of IVF Cycles, 2014–2021
5.15.2 Other Europe IVF Market, 2014–2021 ($Million)
5.16 Other Europe IVF Market by End Users
5.16.1 Market Dynamics
5.16.1.1 Drivers
5.16.1.1.1 WIDE AVAILABILITY OF REIMBURSEMENTS
5.16.1.1.2 EMERGENCE OF NEW FERTILITY DESTINATIONS
5.16.1.1.3 CHANGES IN LIFESTYLE
5.16.1.2 Restraints
5.16.2 Regulatory Issues, Legislations and Authorities
5.16.3 Insurance Reimbursement Scenario
5.16.4 Company Profiles
5.16.4.1 Gynaecoloqisch Centrum
5.16.4.2 centrum voor medische genetica
5.16.4.3 Infertility-Väestöliitto

Chapter: 6 ASIA-PACIFIC IVF MARKET (REVENUE AND NUMBER OF CYCLES)
6.1 India IVF Market (Revenue and Number of Cycles)
6.1.1 Number of IVF Cycles, 2014–2021
6.1.2 India IVF Market, 2014–2021 ($Million)
6.2 India IVF Market by End Users
6.2.1 Market Dynamics
6.2.1.1 Drivers
6.2.1.2 Restraints
6.2.2 Regulatory Issues, Legislations and Authorities
6.2.3 Insurance Reimbursement Scenario
6.2.4 Company Profile
6.2.4.1 Sun Pharmaceutical
6.2.4.2 Trivector Origio Scientific Pvt. Ltd
6.2.4.3 LabIVF Asia Pte. Ltd
6.2.4.4 LG Life Sciences.
6.2.4.5 Cadila Healthcare Ltd.( Zydus Cadila group)
6.2.4.6 Bourn Hall Clinic
6.2.4.7 Southend Fertility and IVF Centre
6.2.4.8 Morpheus IVF Fertility Center
6.2.4.9 Bloom Fertility Center
6.2.4.10 Manipal Ankur
6.2.4.11 Cloudnine
6.2.4.12 Nova IVI Fertility
6.3 China IVF Market (revenue and number of cycles)
6.3.1 Number of IVF Cycles, 2014–2021
6.3.2 China IVF Market, 2014–2021 ($Million)
6.4 China IVF Market by End User
6.4.1 Market Dynamics
6.4.1.1 Drivers
6.4.1.1.1 INCREASED RATE OF INFERTILITY
6.4.1.1.2 CHANGE IN LIFESTYLE
6.4.1.2 Restraints
6.4.1.2.1 COST OF LIVING
6.4.1.2.2 ONE CHILD POLICY
6.4.2 Regulatory Issues, Legislations and Authorities
6.4.3 Insurance Reimbursement Scenario
6.4.4 Company profile
6.4.4.1 Cook Medical, Inc.
6.4.4.2 Vitrolife AB
6.4.4.3 Reproductive and genetic Hospital Citic-Xiangya
6.4.4.4 Shenyang Hospital
6.4.4.5 Shandong Provincial Hospital
6.4.4.6 Centre for Reproductive Medicine
6.5 Japan IVF Market (Revenue annd Number Of Cycles)
6.5.1 Number of IVF Cycles, 2014–2021
6.5.2 Japan IVF Market, 2014–2021 ($Million)
6.6 Japan IVF Market by End-Users
6.6.1 Market Dynamics
6.6.1.1 Drivers
6.6.1.2 Restraints
6.6.2 Regulatory Issues, Legislations and Authorities
6.6.3 Insurance Reimbursement Scenario
6.6.4 Company Profile
6.6.4.1 EMD Serono, Inc
6.6.4.2 IVF NAMBA Clinic
6.6.4.3 Iwaki Women’s Clinic
6.6.4.4 Sanno Hospital
6.7 Australia IVF Market (Revenue annd Number Of Cycles)
6.7.1 Number of IVF Cycles, 2014–2021
6.7.2 Australia IVF Market, 2014–2021 ($Million)
6.8 Australia IVF Market by End Users
6.8.1 Market Dynamics
6.8.1.1 Drivers
6.8.1.2 Restraints
6.8.1.2.1 EMOTIONAL AND PHYSICAL STRESS
6.8.1.2.2 NO GUARANTEE FOR THE SUCCESSFUL TREATMENTS
6.8.1.2.3 SURPLUS EMBRYOS
6.8.2 Regulatory Issues, Legislations and Authorities
6.8.3 Insurance Reimbursement Scenario
6.8.4 Company Profile
6.8.4.1 Genea Biomedx
6.8.4.2 Thermo Fisher Scientific Inc.
6.8.4.3 Virtus Health limited
6.8.4.4 Monash IVF
6.8.4.5 City Fertility center, brisbane
6.8.4.6 Flinders Fertility clinic
6.9 New Zealand IVF Market (Revenue and Number of Cycles)
6.9.1 Number of IVF Cycles, 2014–2021
6.9.2 New Zealand IVF Market, 2014–2021 ($Million)
6.10 New Zealand IVF Market by End users
6.10.1 Market Dynamics
6.10.1.1 Drivers
6.10.1.2 Restraints
6.10.2 Regulatory Issues, Legislations and Authorities
6.10.3 Insurance Reimbursement Scenario
6.10.4 Company Profiles
6.10.4.1 Fertility Associates
6.10.4.2 Fertility Plus
6.10.4.3 Repromed
6.11 Korea IVF Market (Revenue and Number of Cycles)
6.11.1 Number of IVF Cycles, 2014–2021
6.11.2 Korea IVF Market, 2014–2021 ($Million)
6.12 Korea IVF Market by End Users
6.12.1 Market Dynamics
6.12.1.1 Drivers
6.12.1.2 Restraints
6.12.2 Regulatory Issues, legislations and Authorities
6.12.3 Insurance Reimbursement Scenario
6.12.4 Company Profiles
6.12.4.1 Cha General Hospital
6.12.4.2 MARIA Fertility Hospital
6.13 Thailand IVF Market (Revenue and number of Cycles)
6.13.1 Number of IVF Cycles, 2014–2021
6.13.2 Thailand IVF Market, 2014–2021 ($Million)
6.14 Thailand IVF Market by End Users
6.14.1 Market Dynamics
6.14.1.1 Drivers
6.14.1.1.1 GOVERNMENT INITIATIVES
6.14.1.1.2 ECONOMICAL CONSIDERATIONS
6.14.1.1.3 BOOST IN MEDICAL TOURISM
6.14.1.2 Restraints
6.14.1.2.1 COMPARATIVELY LOW SUCCESS RATE
6.14.1.2.2 ETHICAL ISSUES IN ALLOWING GENDER SELECTION
6.14.2 Regulatory Issues, legislations and Authorities
6.14.3 Insurance Reimbursement Scenario
6.14.4 Company Profiles
6.14.4.1 Bangkok Fertility Center
6.14.4.2 Siriraj Hospital
6.14.4.3 Ramathibodi Hospital
6.14.4.4 Perfect Woman Institute
6.14.4.5 Jetanin Institute for Assisted Reproduction
6.15 Other Asia-Pacific IVF Market (Revenue and Number of Cycles)
6.15.1 Number of IVF Cycles, 2014–2021
6.15.2 Other Asia-Pacific IVF Market, 2014–2021 ($Million)
6.16 Other Asia-Pacific IVF Market by End Users
6.16.1 Market Dynamics
6.16.1.1 Drivers
6.16.1.1.1 INCREASE IN DISPOSABLE INCOME
6.16.1.1.2 ADVANCES IN IVF TECHNOLOGY
6.16.1.1.3 DECLINE IN FERTILITY RATE
6.16.1.2 Restraints
6.16.1.2.1 PHYSICAL AND EMOTIONAL IMPACT DUE TO LOW SUCCESS RATE
6.16.2 Regulatory Issues, legislations and Authorities
6.16.3 Insurance Reimbursement Scenario
6.16.4 Company Profiles
6.16.4.1 Fertility Centre, Siloam Hospitals Surabana
6.16.4.2 CRM-MIA-Philippines
6.16.4.3 IVFAS

Chapter: 7 LAMEA IVF MARKET (REVENUE AND NUMBER OF CYCLES)
7.1 Latin America IVF Market (Revenue and Number of Cycles)
7.1.1 Number of IVF Cycles, 2014–2021
7.1.2 Latin America IVF Market, 2014–2021 ($Million)
7.1.3 Number of Infertility Centers
7.2 Latin America IVF Market by End users
7.2.1 Market Dynamics
7.2.1.1 Drivers
7.2.1.1.1 RISING MEDICAL TOURISM IN LATIN AMERICAN COUNTRIES
7.2.1.1.2 LIFTED ITS BAN ON IVF TREATMENTS IN COUNTRIES SUCH AS COSTA RICA
7.2.1.2 Restraints
7.2.1.2.1 HIGH INFANT MORTALITY RATES IN BRAZIL
7.2.2 Regulatory Issues, legislations and Authorities
7.2.3 Insurance Reimbursement Scenario
7.2.4 Profiles of Major Players
7.2.4.1 Clinica Anglo Americana
7.2.4.2 IVF Panama Centro De Reproduccion
7.2.4.3 Insemer
7.2.4.4 Almater Hospital
7.2.4.5 San Fernando Hospital
7.3 Middle East IVF Market (Revenue and Number of Cycles)
7.3.1 Middle East IVF Market, 2014–2021 ($Million)
7.3.2 Number of infertility centers
7.4 Middle East IVF Market by End users
7.4.1 Market Dynamics
7.4.1.1 Drivers
7.4.1.1.1 HIGH-TECH CULTURE IN THE MIDDLE EAST COUNTRIES
7.4.1.1.2 WIDE AVAILABILITY OF REIMBURSEMENTS
7.4.1.2 Restraints
7.4.1.2.1 STRINGENT GOVERNMENT REGULATIONS IN MUSLIM MIDDLE EASTERN REGIONS
7.4.2 Regulatory Issues, Legislations and Authorities
7.4.3 Insurance Reimbursement Scenario
7.4.4 Company Profile
7.4.4.1 Cyprus IVF Centre
7.4.4.2 Al Bushra Medical Specialty Complex
7.4.4.3 Reproductive Medicine Unit at Corniche Hospital (Corniche Fertility center)
7.4.4.4 Trakya University Hospital ART Center
7.5 Africa IVF Market (Revenue and Number of Cycles)
7.5.1 Number of IVF Cycles, 2014–2021
7.5.2 Africa IVF Market, 2014–2021 ($Million)
7.5.3 Number of infertility centers
7.6 Africa IVF Market by End users
7.6.1 Market Dynamics
7.6.1.1 Drivers
7.6.1.1.1 LOW IVF TREATMENT COSTS
7.6.1.1.2 RISING FERTILITY TOURISM IN SOUTH AFRICA
7.6.1.2 Restraints
7.6.1.2.1 SUSCEPTIBILITY TOWARD FIBROIDS
7.6.2 Regulatory Issues, legislations and Authorities
7.6.3 Insurance Reimbursement Scenario
7.6.4 Company Profile
7.6.4.1 Lifesure Fertility & Gynaecology Centre
7.6.4.2 Bethany Women and Family Hospital
7.6.4.3 BioART Fertility Centre
7.6.4.4 DEL International Hospital & Fertility Centre
7.6.4.5 Gift ov life
7.6.4.6 Durban Fertility Clinic
7.6.4.7 Cape fertility clinic

List of Tables
Table 1 Number Of IVF Cycles By Region, 2014-2021 (Thousand)
Table 2 Number Of IVF Cycles By Region, 2014-2021 ($Million)
Table 3 Pricing Trends By Country, 2014
Table 4 Number Of IVF Cycles By Countries, 2014-2021 (Thousand)
Table 5 Global IVF Cycles By End User, 2014 – 2021 (Thousand)
Table 6 Global IVF Revenue By End User, 2014 – 2021 ($Million)
Table 7 IVF Success Rates According To Age
Table 8 North America IVF Cycles, 2014 - 2021 (Thousand)
Table 9 North America IVF Market 2014 - 2021 ($Million)
Table 10 Fresh Embryo Transfer From Non-Donor Oocytes, United States, 2013
Table 11 Thawed Embryo Transfer From Non-Donor Oocytes, United States, 2013
Table 12 Donor Oocytes (For All Ages), United States, 2013
Table 13 United States IVF Cycles, 2014 - 2021 (Thousand)
Table 14 United States IVF Market 2014 - 2021 ($Million)
Table 15 Number Of Fertility Clinics In United States (2014)
Table 16 United States IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 17 United States IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 18 Fertility And Gynecology Center Monterey Bay IVF Business Overview
Table 19 Snapshot Of Fertility And Gynecology Center Monterey Bay
Table 20 Conceptions Reproductive Associates Business Overview
Table 21 Snapshot Of Conceptions Reproductive Associates
Table 22 Servy Massey Fertility Institute Business Overview
Table 23 Snapshot Of Servy Massey Fertility Institute
Table 24 Sher Institute For Reproductive Medicine (Sirm)Business Overview
Table 25 Snapshot Of Institute For Reproductive Medicine (Sirm)
Table 26 Cardone Reproductive Medicine & Infertility Business Overview
Table 27 Snapshot Of Cardone Reproductive Medicine & Infertility
Table 28 Fertility Center Of San Antonio Business Overview
Table 29 Snapshot Of Fertility Center Of San Antonio
Table 30 Houston Fertility Center Business Overview
Table 31 Snapshot Of Houston Fertility Center
Table 32 New Hope Fertility Center Business Overview
Table 33 Snapshot Of Houston Fertility Center
Table 34 Reproductive Medicine Associates Of New Jersey Business Overview
Table 35 Snapshot Of Houston Fertility Center
Table 36 Summary For IVFProcedures, Canada, 2012
Table 37 Cycle Outcomes For IVFProcedures, Canada, 2012
Table 38 Number Of IVF Cycles, Canada, 2014 - 2021 (Thousand)
Table 39 Canada IVF Market 2014 - 2021 ($Million)
Table 40 Canada IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 41 Canada IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 42 Business Overview
Table 43 Snapshot Of Toronto Centre For Advanced Reproductive Technology Ltd.
Table 44 Fertility Treatment Center Business Overview
Table 45 Snapshot Of Fertility Treatment Center
Table 46 Fertility Treatment Center Business Overview
Table 47 Snapshot Of Fertility Treatment Center
Table 48 Summary For IVF Market, Mexico, 2010
Table 49 Number Of IVF Cycles, Mexico, 2014 - 2021 (Thousand)
Table 50 Mexico IVF Market 2014 - 2021 ($Million)
Table 51 Mexico IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 52 Mexico IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 53 Liv Fertility Center In Puerto Vallarta Business Overview
Table 54 Snapshot Of Fertility Treatment Center
Table 55 Biofertility Center In Gudalajara Business Overview
Table 56 Snapshot Of Fertility Treatment Center
Table 57 Number Of IVF Cycles, Europe, 2014 - 2021 (Thousand)
Table 58 Europe IVF Market 2014 - 2021 ($Million)
Table 59 Number Of IVF Cycles, Germany, 2014–2021 (Thousand)
Table 60 Germany IVF Market 2014–2021 ($Million)
Table 61 Germany IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 62 Germany IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 63 Heidelberg University Hospital Business Overview
Table 64 Snapshot Of Heidelberg University Hospital
Table 65 Klinikum Stuttgart Business Overview
Table 66 Company Snapshot
Table 67 Drk Kliniken Berlin Business Overview
Table 68 Snapshot Of Drk Kliniken Berlin
Table 69 University Medical Center Freiburg Business Overview
Table 70 Snapshot Of University Medical Center Freiburg
Table 71 Number Of IVF Cycles, France, 2014–2021 (Thousand)
Table 72 France IVF Market 2014–2021 ($Million)
Table 73 France IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 74 France IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 75 Clinique De La Muette Business Overview
Table 76 Snapshot Of Clinique De La Muette
Table 77 Hopital Des Metallurgists, Hopital Cochin Business Overview
Table 78 Snapshot Of Hopital Des Metallurgists, Hopital Cochin
Table 79 IVF Cycles By Various Age Groups, United Kingdom, 2011
Table 80 Proportion Of IVF Cycles Using Fresh And Frozen Eggs, United Kingdom, 2010-2011
Table 81 IVF Success Rates In United Kingdom (As Per Nhs), 2010
Table 82 Regional IVF Clinics And Total Number Of Women Treated, United Kingdom, 2011
Table 83 United Kingdom IVF Cycles, 2014–2021 (Thousand)
Table 84 United Kingdom IVF Market 2014–2021 ($Million)
Table 85 United Kingdom IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 86 United Kingdom IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 87 Lister Fertility Clinic Business Overview
Table 88 Company Snapshot
Table 89 The Bridge Center Business Overview
Table 90 Snapshot Of The Bridge Center
Table 91 Chelsea And Westminster Hospital Business Overview
Table 92 Snapshot Of Chelsea And Westminster Hospital
Table 93 Italy IVF Cycles, 2014–2021 (Thousand)
Table 94 Italy IVF Market 2014–2021 ($Million)
Table 95 Italy IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 96 Italy IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 97 Spain IVF Cycles, 2014–2021 (Thousand)
Table 98 Spain IVF Market 2014–2021 ($Million)
Table 99 Spain IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 100 Spain IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 101 Denmark, IVF Cycles, 2014–2021 (Thousand)
Table 102 Denmark IVF Market 2014–2021 ($Million)
Table 103 Denmark IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 104 Denmark IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 105 Russia IVF Cycles, 2014–2021 (Thousand)
Table 106 Russia IVF Market 2014–2021 ($Million)
Table 107 Russia IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 108 Russia IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 109 Other Europe IVF Cycles, 2014–2021 (Thousand)
Table 110 Other Europe IVF Market 2014–2021 ($Million)
Table 111 Other Europe IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 112 Other Europe IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 113 Number Of IVF Cycles, Asia-Pacific, 2014 - 2021 (Thousand)
Table 114 Asia-Pacific IVF Market 2014 - 2021 ($Million)
Table 115 India IVF Cycles, 2014–2021 (Thousand)
Table 116 India IVF Market 2014–2021 ($Million)
Table 117 India IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 118 India IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 119 Sun Pharmaceutical Business Overview
Table 120 Snapshot Of Sun Pharmaceutical
Table 121 Trivector Origio Scientific Business Overview
Table 122 Snapshot Of Trivector Origio
Table 123 Lab IVFAsia Business Overview
Table 124 Snapshot Of Lab IVFAsia
Table 125 LG Life Science Business Overview
Table 126 Snapshot Of LG Life Science
Table 127 Cadila Health Care Business Overview
Table 128 Snapshot Of Cadila Health Care
Table 129 Bourn Hall Business Overview
Table 130 Southend Fertility And IVF Centre Business Overview
Table 131 Morpheus IVF Fertility Center Business Overview
Table 132 Bloom Fertility Center Business Overview
Table 133 Manipal Ankur Business Overview
Table 134 Cloudnine Business Overview
Table 135 Nova Ivi Fertility Business Overview
Table 136 China IVF Cycles, 2014–2021 (Thousand)
Table 137 China IVF Market 2014–2021 ($Million)
Table 138 China IVF Cycles By End Users, 2014– 2021 (Thousand)
Table 139 China IVF Market Revenue By End Users, 2014– 2021 ($Million)
Table 140 Cook Medical Inc Business Overview
Table 141 Snapshot Of Cook Medical Inc.
Table 142 Vitrolife Ab Inc., Business Overview
Table 143 Snapshot Of Vitrolife Ab Inc.
Table 144 Reproductive And Genetic Hospital Citic-Xiangya, Business Overview
Table 145 Shenyang Hospital Business Overvie
Table 146 Shandong Provincial Hospital Business Overview
Table 147 Centre For Reproductive Medicine, Business Overview
Table 148 Japan IVF Cycles, 2014–2021 (Thousand)
Table 149 Japan IVF Market 2014–2021 ($Million)
Table 150 Japan IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 151 Japan IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 152 Emd Serono Inc Business Overview
Table 153 Snapshot Of Emd Serono Inc
Table 154 IVF Namba Clinic Business Overview
Table 155 Iwaki Women’s Clinic Business Overview
Table 156 Sanno Hospital Business Overview
Table 157 Australia IVF Cycles, 2014–2021 (Thousand)
Table 158 Australia IVF Market 2014–2021 ($Million)
Table 159 Outcomes Of Cycles Of IVF By Women’s Age Group, 2011
Table 160 Australia IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 161 Australia IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 162 Genea Biomedx Technologies Business Overview
Table 163 Snapshot Of Genea Biomedx Technologies
Table 164 Snapshot Of Thermo Fisher Scientific Inc.
Table 165 Thermo Fisher Scientific Inc. Business Overview
Table 166 Virtus Health Business Overview
Table 167 Monash IVF Business Overview
Table 168 City Fertility Business Overview
Table 169 Flinders Fertility Business Overview
Table 170 New Zealand IVF Cycles, 2014–2021 (Thousand)
Table 171 New Zealand IVF Market 2014–2021 ($Million)
Table 172 New Zealand IVF Revenue By End Users, 2014 – 2021 ($Million)
Table 173 New Zealand IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 174 Korea IVF Cycles, 2014–2021 (Thousand)
Table 175 New Zealand IVF Market 2014–2021 ($Million)
Table 176 Korea IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 177 Korea IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 178 Thailand IVF Cycles, 2014–2021 (Thousand)
Table 179 Thailand IVF Market 2014–2021 ($Million)
Table 180 Thailand IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 181 Thailand IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 182 Other Asia-Pacific IVF Cycles, 2014–2021 (Thousand)
Table 183 Other Asia-Pacific IVF Market 2014–2021 ($Million)
Table 184 Other Asia-Pacific IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 185 Other Asia-Pacific IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 186 Lamea IVF Cycles, 2014 - 2021 (Thousand)
Table 187 Lamea IVF Market 2014 - 2021 ($Million)
Table 188 Latin America IVF Cycles, 2014–2021 (Thousand)
Table 189 Latin America IVF Market 2014–2021 ($Million)
Table 190 Latin America IVF Cycles By End Users, 2014– 2021 (Thousand)
Table 191 Latin America IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 192 Clinica Anglo Americana Business Overview
Table 193 Snapshot Of Clinica Anglo Americana
Table 194 IVF Panama Centro De Reproduccion Punta Pacifica Business Overview
Table 195 Snapshot Of IVF Panama Centro De Reproduction Punta Pacifica
Table 196 Insamer Business Overview
Table 197 Company Snapshot
Table 198 Almater Hospital Business Overview
Table 199 Company Snapshot
Table 200 San Fernando Hospital Business Overview
Table 201 Company Snapshot
Table 202 Middle East IVF Cycles, 2014–2021 (Thousand)
Table 203 Middle East IVF Market 2014–2021 ($Million)
Table 204 Middle East IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 205 Middle East IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 206 Cyprus IVF Centre Business Overview
Table 207 Company Snapshot
Table 208 Al Bushra Medical Specialty Complex Business Overview
Table 209 Company Of Al Bushra Medical Specialty Complex
Table 210 Reproductive Medicine Unit At Corniche Hospital Business Overview
Table 211 Snapshot Of Reproductive Medicine Unit At Corniche Hospital
Table 212 Trakya University Hospital Art Center Business Overview
Table 213 Snapshot Of Trakya University Hospital Art Center
Table 214 Africa IVF Cycles, 2014–2021 (Thousand)
Table 215 Africa IVF Market 2014–2021 ($Million)
Table 216 Africa IVF Cycles By End Users, 2014 – 2021 (Thousand)
Table 217 Africa IVF Market Revenue By End Users, 2014 – 2021 ($Million)
Table 218 Lifesure Fertility & Gynaecology Centre Business Overview
Table 219 Company Snapshot
Table 220 Bethany Women And Family Hospital Business Overview
Table 221 Company Snapshot
Table 222 Bioart Fertility Centre Business Overview
Table 223 Company Snapshot
Table 224 Del International Hospital & Fertility Centre Business Overview
Table 225 Company Snapshot
Table 226 Gift Ov Life Business Overview
Table 227 Company Snapshot
Table 228 Durban Fertility Clinic Business Overview
Table 229 Company Snapshot
Table 230 Cape Fertility Clinic Business Overview
Table 231 Company Snapshot

List of Figures
Fig. 1 Global IVF Market, 2014 – 2021 ($Million)
Fig. 2 Number Of Global IVF Cycles, 2014 – 2021 (Thousand)
Fig. 3 Regulatory Scenario, United States
Fig. 4 Regulatory Scenario, Canada
Fig. 5 Regulatory Scenario, Mexico
Fig. 6 Regulatory Scenario, Germany
Fig. 7 Regulatory Scenario, France
Fig. 8 Regulatory Scenario, United Kingdom
Fig. 9 Total Fertility Rate (Children Born/ Women)
Fig. 10 China Fertility Rate (Children Born/Women)
Fig. 11 Total Fertility Rate (Children Born/ Women)
Fig. 12 Total Fertility Rate (Children Born/ Women)
Fig. 13 IVF Success Rate For Australia
Fig. 14 Total Fertility Rate (Children Born/ Women)
Fig. 15 Total Fertility Rate (Children Born/Women) - South Korea
Fig. 16 Thailand Fertility Rate Child Born/Women
Fig. 17 Regulatory Scenario, Latin America
Fig. 18 Regulatory Scenario, Middle East
Fig. 19 Regulatory Scenario, Africa

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cadila Healthcare Ltd.
  • Clinica Anglo Americana
  • Clinique de la Muette
  • EMD Serono
  • Genea Biomedx
  • Klinikum Stuttgart
  • MORE

A new report titled, "Global IVF Services Market - Country Analysis by Service Providers, Number of Cycles, Revenue, Market Share, Growth, Trends, and Forecast, 2014-2021", forecasts the global IVF market to reach $11.3 billion by 2021. United States would continue to lead the market through 2021 and would have 321.7 thousand IVF cycles performed in 2021. Globally, India is projected to register highest growth both in terms of number of cycles and revenue.The key factors that influence the growth of IVF cycles include, delayed pregnancy; a factor that is increasingly gaining prominence in developed economies, rise in infertility rates and increase in healthcare expenditures. Moreover, growing acceptance of the 3-parent IVF technique further contributing to the market growth. These factors would facilitate the number of cycles performed to reach 3,122.2 thousands by 2021, globally. On contrary, stringent regulations, limited success ratio and high costs of treatment would limit the market growth. Active initiatives by government, such as IVF refund programs, donor egg IVF programs, development of cost-effective IVF techniques and increasing popularity of fertility tourism would spur the market growth.Fertility clinics and hospitals segment collectively contributed about three-fourth of the global market revenue in 2014. Such large share of these segments is attributed to their crucial role in providing the technologically advanced IVF treatment to couples seeking assistance for infertility treatment. Geographically, the United States, China, and India, collectively holds about 42% of the market (IVF cycles) share due to increased rate of infertility and practices of embryo banking cycles, rising fertility tourism, and delayed parenthood decisions. On the other hand, Turkey, Israel, Brazil, Mexico would emerge as key fertility tourism destinations during the forecast period mainly due to favorable government regulations and economic availability of skilled workforce and hospitality services.

Key findings of the study:

- In India, fertility clinics and hospitals segment collectively accounted for about 4/5th of the revenue generated in 2014
- The Asia-Pacific IVF market is expected to grow at a promising CAGR of 8.9% from 2015 to 2021 in terms of volume China leads the Asia Pacific IVF market with about 44% volume share
- Key players profiled in this report included Fertility and Gynecology Center, Monterey Bay IVF, Conceptions Reproductive Associates, Toronto Center for Advanced reproductive Technology Ltd., Liv Fertility Center in Puerto Vallarta, Klinikum Stuttgart, Heidelberg University Hospital, Clinique de la Muette, The Bridge Center, Sun Pharmaceuticals, Cadila Healthcare Ltd., LG Lifesciences, Vitrolife AB., EMD Serono, Inc., Thermo Fisher Scientific Inc., Genea Biomedx, Clinica Anglo Americana, Cyprus IVF Center Lifesure Fertility & Gynecology Center and others.

Note: Product cover images may vary from those shown

- Cadila Healthcare Ltd.
- Clinica Anglo Americana
- Clinique de la Muette
- Conceptions Reproductive Associates
- Cyprus IVF Center Lifesure Fertility & Gynecology Center
- EMD Serono
- Fertility and Gynecology Center
- Genea Biomedx
- Heidelberg University Hospital
- Klinikum Stuttgart
- LG Lifesciences
- Liv Fertility Center in Puerto Vallarta
- Monterey Bay IVF
- Sun Pharmaceuticals
- The Bridge Center
- Thermo Fisher Scientific Inc.
- Toronto Center for Advanced reproductive Technology Ltd.
- Vitrolife AB.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: A printed copy of the report will be shipped to you.

  • Quick Help: The report will be shipped to you in CD ROM format.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Actavis
  • Smith & Nephew PLC.
  • Bayer AG
  • Hologic Corporation
  • Abbott Laboratories Ltd.
  • Polpharma SA